MoneyBloomberg Markets
CanSino CEO Xuefeng Yu on Earnings, Pipeline
Xuefeng Yu, Chairman & CEO of CanSino Biologics, discusses the Chinese vaccine maker's first-half results and clinical pipeline. He speaks exclusively on "Bloomberg: The China Show." (Source: Bloomberg)
Join the argument
House rules βComments load as you scroll.